You do not have the latest flash plugin or you have disabled javascript.

Pharmaceuticals Blog

Congress gets involved with Johnson & Johnson, FDA over stents

August 15th, 2007 by Todd Hageman

The Washington Post and Pharmalot report that lawmakers have sent letters to Johnson & Johnson and the U.S. Food and Drug Administration asking why Cypher stents were allowed to be sold after inspections and studies released as early as 2004 showed numerous manufacturing problems.

The Aug. 13 letters to the FDA and Johnson & Johnson were sent by U.S. Rep. John Dingell, chairman of the House Committee on Energy and Commerce, and U.S. Rep. Bart Stupak, chairman of the Subcommittee on Oversight and Investigations. Both lawmakers are Michigan Democrats.

If you or someone you know has encountered problems with stents, please contact Todd Hageman toll free at 1-877-767-3108.

 

Simon Passanante is nationally recognized as a result of its successful handling of jury trials on a wide variety of cases. You are invited to view the firm’s notable verdicts and settlements. Much of the information on this site is presented through videos. Other pages of this site concern Simon Passanante’s honors and awards, testimonials from clients and referring attorneys, and safety information. Our employee directory is here. If you have any questions for us, email us. See this page for important legal disclosures and to learn about contingent fees. For updates regarding Simon Passanante, we invite you to explore our law blogs.

Simon Passanante PC

701 Market Street

Suite 1450

St. Louis, Missouri 63101

Toll Free: 877.767.3108

Fax: 314.241.2029

Close
E-mail It